ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
57.25
-1.27 (-2.16%)
Oct 31, 2024, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 76.8, with a low estimate of 62 and a high estimate of 94. The average target predicts an increase of 34.16% from the current stock price of 57.25.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ANIP stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $60 → $62 | Hold | Maintains | $60 → $62 | +8.31% | Oct 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $68 | Buy | Initiates | $68 | +18.79% | Oct 11, 2024 |
| Raymond James | Raymond James | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +44.99% | Sep 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $94 | Strong Buy | Reiterates | $94 | +64.21% | Sep 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $80 → $60 | Strong Buy → Hold | Downgrades | $80 → $60 | +4.81% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
595.03M
from 486.82M
Increased by 22.23%
Revenue Next Year
695.22M
from 595.03M
Increased by 16.84%
EPS This Year
4.77
from 0.85
Increased by 460.65%
EPS Next Year
5.35
from 4.77
Increased by 12.07%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 624.8M | 762.9M | 808.0M | ||
| Avg | 595.0M | 695.2M | 772.6M | ||
| Low | 543.2M | 541.0M | 732.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 28.3% | 28.2% | 16.2% | ||
| Avg | 22.2% | 16.8% | 11.1% | ||
| Low | 11.6% | -9.1% | 5.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.01 | 6.04 | 7.01 | ||
| Avg | 4.77 | 5.35 | 6.15 | ||
| Low | 4.55 | 4.76 | 5.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 488.2% | 26.5% | 31.1% | ||
| Avg | 460.7% | 12.1% | 14.9% | ||
| Low | 434.1% | -0.2% | 2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.